183 related articles for article (PubMed ID: 33436504)
1. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
Li D; Huang X; Shi M; Luo L; Tao C
Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
[TBL] [Abstract][Full Text] [Related]
2. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
[TBL] [Abstract][Full Text] [Related]
3. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
4. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
[TBL] [Abstract][Full Text] [Related]
5. Has CXCL13 an added value in diagnosis of neurosyphilis?
Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal Synthesis Index of Specific Anti-
Alberto C; Deffert C; Lambeng N; Breville G; Gayet-Ageron A; Lalive P; Toutous Trellu L; Fontao L
Microbiol Spectr; 2022 Feb; 10(1):e0147721. PubMed ID: 35138118
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
[TBL] [Abstract][Full Text] [Related]
9. Multicentric evaluation of a specific intrathecal anti-
Alberto C; Lambeng N; Deffert C; Breville G; Gayet-Ageron A; Lalive P; Calmy A; Coste A; Papadimitriou-Olivgeris M; Braun D; Lienhard R; Bosshard PP; Fontao L; Toutous Trellu L
Sex Transm Infect; 2024 Feb; 100(2):63-69. PubMed ID: 38071543
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
11. Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study.
Lu Y; Ke W; Yang L; Wang Z; Lv P; Gu J; Hao C; Li J; Cai Y; Gu M; Liu H; Chen W; Zhang X; Wang L; Liu Y; Yang B; Zou H; Zheng H
BMC Infect Dis; 2019 Dec; 19(1):1017. PubMed ID: 31791265
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
13. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
Marra CM
Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.
Marra CM; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC
J Clin Microbiol; 2017 Jun; 55(6):1865-1870. PubMed ID: 28381602
[TBL] [Abstract][Full Text] [Related]
15. Biological false-positive venereal disease research laboratory test in cerebrospinal fluid in the diagnosis of neurosyphilis - a case-control study.
Zheng S; Lin RJ; Chan YH; Ngan CCL
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):474-481. PubMed ID: 29117430
[TBL] [Abstract][Full Text] [Related]
16. A comparison of nontreponemal tests in cerebrospinal fluid for neurosyphilis diagnosis: equivalent detection of specific antibodies.
Versiani I; Cabral-Castro MJ; Puccioni-Sohler M
Arq Neuropsiquiatr; 2019 Feb; 77(2):91-95. PubMed ID: 30810592
[TBL] [Abstract][Full Text] [Related]
17. Screening for syphilis and neurosyphilis in acute psychiatric admissions.
Roberts MC; Emsley RA; Jordaan GP
S Afr Med J; 1992 Jul; 82(1):16-8. PubMed ID: 1641712
[TBL] [Abstract][Full Text] [Related]
18. Significance of laboratory findings for the diagnosis of neurosyphilis.
Luger AF; Schmidt BL; Kaulich M
Int J STD AIDS; 2000 Apr; 11(4):224-34. PubMed ID: 10772085
[TBL] [Abstract][Full Text] [Related]
19. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.
Marra CM; Tantalo LC; Maxwell CL; Ho EL; Sahi SK; Jones T
Sex Transm Dis; 2012 Jun; 39(6):453-7. PubMed ID: 22592831
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China.
Zhu L; Gu X; Peng RR; Wang C; Gao Z; Zhou P; Gao Y; Shi M; Guan Z; Seña AC
J Clin Microbiol; 2014 Mar; 52(3):736-40. PubMed ID: 24335955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
